mAbs

Λεπτομέρειες βιβλιογραφικής εγγραφής
Μορφή: journal
Γλώσσα:English
Έκδοση: Taylor & Francis Group 2021
Θέματα:
Διαθέσιμο Online:https://doaj.org/toc/1942-0870
id oai:doaj.org-journal:35d219da09c84009a1af37a5f3f7bc9e
record_format dspace
spelling oai:doaj.org-journal:35d219da09c84009a1af37a5f3f7bc9e2023-07-18T15:26:08ZmAbs1942-08701942-0862https://doaj.org/toc/1942-0870ENCC BYCC BY-NCTaylor & Francis Grouphttps://www.tandfonline.com/journals/kmabhttps://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=kmab20https://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=kmab202021-05-10T13:02:02Zjournalimmunologyantibodiescancerantibody therapeuticsantibody engineeringTherapeutics. PharmacologyRM1-950Immunologic diseases. AllergyRC581-607
institution DOAJ
collection DSpace
language English
topic immunology
antibodies
cancer
antibody therapeutics
antibody engineering
Therapeutics. Pharmacology
RM1-950
Immunologic diseases. Allergy
RC581-607
spellingShingle immunology
antibodies
cancer
antibody therapeutics
antibody engineering
Therapeutics. Pharmacology
RM1-950
Immunologic diseases. Allergy
RC581-607
mAbs
format journal
title mAbs
title_short mAbs
title_full mAbs
title_fullStr mAbs
title_full_unstemmed mAbs
title_sort mabs
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/toc/1942-0870
_version_ 1801185051912699904